Monospecific antibodies and assay system for detecting stromelysin
cleavage products
    9.
    发明授权
    Monospecific antibodies and assay system for detecting stromelysin cleavage products 失效
    单特异性抗体和用于检测溶基质解酶裂解产物的测定系统

    公开(公告)号:US5387504A

    公开(公告)日:1995-02-07

    申请号:US954213

    申请日:1992-09-30

    摘要: Monospecific antibodies are produced which are specific for fragments of the connective tissue protein aggrecan, generated by specific stromelysin cleavage. These monospecific antibodies are used in an assay system to detect polypeptide fragments of aggrecan, produced by the specific cleavage of aggrecan by stromelysin. The presence of aggrecan polypeptide fragments demonstrates stromelysin activity. Elevations of stromelysin occur in osteoarthritis, rheumatoid arthritis, atherosclerotic lesions, gout, inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF), certain cancers, joint injuries, and numerous inflammatory diseases. The monospecific antibodies and the assay system are used to quantitate aggrecan polypeptide fragments as a readout of stromelysin activity and to evaluate potential stromelysin inhibitors.

    摘要翻译: 产生单特异性抗体,其特异性是通过特异性溶质酶切割产生的结缔组织蛋白聚集蛋白聚糖的片段。 这些单特异性抗体用于测定系统中以检测通过溶基质解素特异性切割聚集蛋白聚糖的聚集蛋白聚糖蛋白聚糖的多肽片段。 聚集蛋白聚糖多肽片段的存在显示了基质溶蛋白酶活性。 骨质疏醇症的升高发生在骨关节炎,类风湿性关节炎,动脉粥样硬化病变,痛风,炎性肠病(IBD),特发性肺纤维化(IPF),某些癌症,关节损伤和许多炎性疾病中。 单特异性抗体和测定系统用于定量聚集蛋白聚糖多肽片段作为溶质蛋白酶活性的读数并评价潜在的溶基质蛋白酶抑制剂。